World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025
Award Badge
Medicine
France
2023

D-Index & Metrics

Best Female Scientists

D-Index
142
Citations
73506
World Ranking
223
National Ranking
9

Medicine

D-Index
143
Citations
74486
World Ranking
1515
National Ranking
39

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award
  • 2023 - Research.com Medicine in France Leader Award

Overview

Sylvie Chevret is affiliated with Université Paris Cité in France and has an extensive publication record primarily in the field of Medicine. Their work spans several subfields including Hematology, Statistics and Probability, Epidemiology, Oncology, and Pulmonary and Respiratory Medicine.

The scientist's research topics cover a breadth of clinical and methodological areas, highlighting Acute Myeloid Leukemia Research, Statistical Methods in Clinical Trials, Advanced Causal Inference Techniques, Health Systems, Economic Evaluations and Quality of Life, COVID-19 Clinical Research Studies, Chronic Myeloid Leukemia Treatments, and Hematopoietic Stem Cell Transplantation.

Frequent publication venues for their research include Blood, Journal of Clinical Oncology, Journal of Hepatology, Bone Marrow Transplantation, and Annals of Oncology. These journals reflect a focus on both clinical and translational hematology and oncology research.

Co-authorship frequently appears with several collaborators, notably Cendrine Chaffaut, Lionel Adès, Fatiha Chermat, Sylvain Thépot, and Pierre Fenaux, indicative of an active participation in collaborative research networks within their field.

Among the recent notable papers authored or co-authored by Sylvie Chevret are:

  • Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma, 2020, Blood Advances
  • Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM), 2021, Journal of Clinical Oncology
  • High-Dose Dexamethasone and Oxygen Support Strategies in Intensive Care Unit Patients With Severe COVID-19 Acute Hypoxemic Respiratory Failure, 2022, JAMA Internal Medicine
  • A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosis, 2020, Blood
  • Plasma exchange in the intensive care unit: a narrative review, 2022, Intensive Care Medicine

Best Publications

  • Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

    Jean Chastre;Michel Wolff;Jean-Yves Fagon;Sylvie Chevret

  • Risk of Post-traumatic Stress Symptoms in Family Members of Intensive Care Unit Patients

    Elie Azoulay;Frédéric Pochard;Nancy Kentish-Barnes;Sylvie Chevret

  • A communication strategy and brochure for relatives of patients dying in the ICU.

    Alexandre Lautrette;Michael Darmon;Bruno Megarbane;Luc Marie Joly

  • A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

    Pierre Fenaux;Claude Chastang;Sylvie Chevret;Miguel Sanz

  • Burnout syndrome in critical care nursing staff

    Marie Cécile Poncet;Philippe Toullic;Laurent Papazian;Nancy Kentish-Barnes

  • Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.

    Vanderson Rocha;Jacqueline Cornish;Eric L. Sievers;Alexandra Filipovich

  • Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study

    Sylvie Castaigne;Cécile Pautas;Christine Terré;Emmanuel Raffoux

  • Symptoms of anxiety and depression in family members of intensive care unit patients: Ethical hypothesis regarding decision-making capacity

    F Pochard;E Azoulay;S Chevret;F Lemaire

  • Half the families of intensive care unit patients experience inadequate communication with physicians.

    E Azoulay;S Chevret;G Leleu;F Pochard

  • Effects of Fluid Resuscitation With Colloids vs Crystalloids on Mortality in Critically Ill Patients Presenting With Hypovolemic Shock: The CRISTAL Randomized Trial

    Djillali Annane;Shidasp Siami;Samir Jaber;Claude Martin

  • Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: A meta-analysis of individual patient data from randomised controlled trials

    Robert Kerrin Hills;Sylvie Castaigne;Frederick R. Appelbaum;Jacques Delaunay

  • High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial.

    Jean-Paul Fermand;Philippe Ravaud;Sylvie Chevret;Marine Divine

  • Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera

    Jean-Jacques Kiladjian;Bruno Cassinat;Sylvie Chevret;Pascal Turlure

  • Outcomes of Critically Ill Patients With Hematologic Malignancies: Prospective Multicenter Data From France and Belgium—A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study

    Elie Azoulay;Djamel Mokart;Frédéric Pène;Jérôme Lambert

  • A new prognostic classification for predicting survival in patients with hepatocellular carcinoma

    Sylvie Chevret;Jean-Claude Trinchet;Didier Mathieu;Antoine Abou Rached

  • Clinical trial of plasma exchange and high‐dose intravenous immunoglobulin in myasthenia gravis

    Philippe Gajdos;Sylvie Chevret;Bernard Clair;Christine Tranchant

  • Outcome of and Prognostic Factors for Herpes Simplex Encephalitis in Adult Patients: Results of a Multicenter Study

    Franck Raschilas;Michel Wolff;Frédérique Delatour;Cendrine Chaffaut

  • Prevalence and Factors of Intensive Care Unit Conflicts The Conflicus Study

    Élie Azoulay;Jean-François Timsit;Charles L. Sprung;Marcio Soares

  • Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients.

    Michel Leporrier;Sylvie Chevret;Bruno Cazin;Najda Boudjerra

  • Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease

    Françoise Bernaudin;Gérard Socie;Mathieu Kuentz;Sylvie Chevret

Frequent Co-Authors

Elie Azoulay
Elie Azoulay Université Paris Cité
Pierre Fenaux
Pierre Fenaux Université Paris Cité
Hervé Dombret
Hervé Dombret Université Paris Cité
Gérard Socié
Gérard Socié Université Paris Cité
Emmanuel Raffoux
Emmanuel Raffoux Hôpital Saint-Louis
Djillali Annane
Djillali Annane University of Paris-Saclay
Sylvie Castaigne
Sylvie Castaigne Versailles Saint-Quentin-en-Yvelines University
Claude Preudhomme
Claude Preudhomme University of Lille
Benoît Schlemmer
Benoît Schlemmer Université Paris Cité
Stéphane de Botton
Stéphane de Botton Institut Gustave Roussy

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical careers in the USA offers a range of pathways, both traditional and online. For those already holding a master’s degree in nursing, consider the shortest post master's dnp program to quickly advance your credentials and leadership skills.

If you’re looking for flexible study options, some online dnp programs without clinicals are available. These programs can be ideal for professionals balancing work and studies, or for those seeking a more theory-focused curriculum.

For aspiring nurses, fast-track pathways can help you enter the workforce sooner. The lpn program offers a practical route for those starting their nursing careers, often with quicker completion times compared to traditional programs.

Mental health is an increasingly important field within medicine. Nurses interested in psychiatric care can streamline their education through the fastest post master's pmhnp pathway, focusing on advanced mental health practice and patient support.

Best Scientists Citing Sylvie Chevret

Trending Scientists